Form 8-K - Current report:
SEC Accession No. 0001104659-25-078617
Filing Date
2025-08-14
Accepted
2025-08-14 16:17:08
Documents
50
Period of Report
2025-08-13
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2523439d1_8k.htm   iXBRL 8-K 35219
2 EXHIBIT 99.1 tm2523439d1_ex99-1.htm EX-99.1 96443
3 EXHIBIT 99.2 tm2523439d1_ex99-2.htm EX-99.2 55836
7 GRAPHIC tm2523439d1_ex99-2img001.jpg GRAPHIC 136955
8 GRAPHIC tm2523439d1_ex99-2img002.jpg GRAPHIC 349391
9 GRAPHIC tm2523439d1_ex99-2img003.jpg GRAPHIC 195405
10 GRAPHIC tm2523439d1_ex99-2img004.jpg GRAPHIC 169707
11 GRAPHIC tm2523439d1_ex99-2img005.jpg GRAPHIC 133116
12 GRAPHIC tm2523439d1_ex99-2img006.jpg GRAPHIC 136723
13 GRAPHIC tm2523439d1_ex99-2img007.jpg GRAPHIC 189326
14 GRAPHIC tm2523439d1_ex99-2img008.jpg GRAPHIC 177743
15 GRAPHIC tm2523439d1_ex99-2img009.jpg GRAPHIC 121785
16 GRAPHIC tm2523439d1_ex99-2img010.jpg GRAPHIC 87644
17 GRAPHIC tm2523439d1_ex99-2img011.jpg GRAPHIC 152468
18 GRAPHIC tm2523439d1_ex99-2img012.jpg GRAPHIC 153862
19 GRAPHIC tm2523439d1_ex99-2img013.jpg GRAPHIC 240811
20 GRAPHIC tm2523439d1_ex99-2img014.jpg GRAPHIC 219255
21 GRAPHIC tm2523439d1_ex99-2img015.jpg GRAPHIC 145251
22 GRAPHIC tm2523439d1_ex99-2img016.jpg GRAPHIC 151832
23 GRAPHIC tm2523439d1_ex99-2img017.jpg GRAPHIC 169507
24 GRAPHIC tm2523439d1_ex99-2img018.jpg GRAPHIC 212177
25 GRAPHIC tm2523439d1_ex99-2img019.jpg GRAPHIC 150147
26 GRAPHIC tm2523439d1_ex99-2img020.jpg GRAPHIC 185745
27 GRAPHIC tm2523439d1_ex99-2img021.jpg GRAPHIC 158549
28 GRAPHIC tm2523439d1_ex99-2img022.jpg GRAPHIC 173938
29 GRAPHIC tm2523439d1_ex99-2img023.jpg GRAPHIC 101641
30 GRAPHIC tm2523439d1_ex99-2img024.jpg GRAPHIC 162155
31 GRAPHIC tm2523439d1_ex99-2img025.jpg GRAPHIC 137899
32 GRAPHIC tm2523439d1_ex99-2img026.jpg GRAPHIC 146565
33 GRAPHIC tm2523439d1_ex99-2img027.jpg GRAPHIC 130074
34 GRAPHIC tm2523439d1_ex99-2img028.jpg GRAPHIC 128099
35 GRAPHIC tm2523439d1_ex99-2img029.jpg GRAPHIC 200265
36 GRAPHIC tm2523439d1_ex99-2img030.jpg GRAPHIC 43177
37 GRAPHIC tm2523439d1_ex99-2img031.jpg GRAPHIC 154211
38 GRAPHIC tm2523439d1_ex99-2img032.jpg GRAPHIC 160353
39 GRAPHIC tm2523439d1_ex99-2img033.jpg GRAPHIC 143945
40 GRAPHIC tm2523439d1_ex99-2img034.jpg GRAPHIC 200337
41 GRAPHIC tm2523439d1_ex99-2img035.jpg GRAPHIC 195214
42 GRAPHIC tm2523439d1_ex99-2img036.jpg GRAPHIC 133924
  Complete submission text file 0001104659-25-078617.txt   8451158

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA ipsc-20250813.xsd EX-101.SCH 3017
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipsc-20250813_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipsc-20250813_pre.xml EX-101.PRE 22360
52 EXTRACTED XBRL INSTANCE DOCUMENT tm2523439d1_8k_htm.xml XML 3812
Mailing Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104
Business Address 25 N 38TH STREET, 11TH FLOOR PHILADELPHIA PA 19104 215-981-4000
Century Therapeutics, Inc. (Filer) CIK: 0001850119 (see all company filings)

EIN.: 842040295 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40498 | Film No.: 251219432
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)